Stock Screener App

Frei -

Installieren

13.24

1.61% 0.21

after-market

Handel nachbörslich: 13.24

Benitec Biopharma Inc (BNTC)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	18.33% 10.19	8.61	5.791	5.548	4.141
Operating Income/Loss	18.33% -10.19	-8.61	-5.791	-5.548	-4.141
Nonoperating Income/Loss	33.44% 0.834	1.253	0.732	0.828	-0.138
Income/Loss From Continuing Operations Before Tax	27.14% -9.354	-7.357	-5.059	-4.72	-4.279
Income/Loss From Continuing Operations After Tax	27.14% -9.354	-7.357	-5.059	-4.72	-4.279
Net Income/Loss	27.14% -9.354	-7.357	-5.059	-4.72	-4.279
Preferred Stock Dividends And Other Adjustments	-	-	-	0.619	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	74.85% 38.60	22.08	10.64	1.6109	2.6163
Diluted Average Shares	74.85% 38.60	22.08	10.64	1.6109	2.6163
Basic Earnings Per Share	27.27% -0.24	-0.33	-0.48	1.70	-1.64
Diluted Earnings Per Share	27.27% -0.24	-0.33	-0.48	1.70	-1.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	0.619	-

GMAB

$24.87

0.96%

INCY

$84.61

1.09%

SMMT

$23.70

2.95%

BNTX

$100.00

1.89%

INSM

$136.10

0.84%

ONC

$306.05

2.72%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters